Michael Ihnat, Ph.D.

Associate Professor

Department of Pharmaceutical Sciences

Phone (405) 271-6593 x47965

Office CPB 319

Email michael-ihnat@ouhsc.edu


Summary

A main focus of the Ihnat laboratory research is on micrometastatic tumor ‘dormancy,’ the period from when micrometastatic cancer cells sit down in the secondary organ/site to the time in which they reactivate. We also have studied the environmental toxicology of metals, arsenic and chromium in particular, for many years and we have recently developed a collaborative project looking at the nephrotoxicity of water-soluble components of lignite coal in drinking water.



Research

Tumor dormancy. Projects in this area include determining the role of aspects of the immune system in dormancy/reactivation, identifying drugs to target dormant cells and modeling aspects of dormancy/reactivation in culture and in animals. We collaborate with many folks including Drs. Randle Gallucci and Lucila Garcia-Contreras in the OU College of Pharmacy; Dr. Jeff Eckert in the Department of Pediatrics/Neonatology; Dr. Aleem Gangjee at Duquesne University; Dr. Pui-Kai Li at The Ohio State; and Drs. David Warshawsky, Robert Hurst and others at Vuja De Sciences, a company devoted to studying tumor dormancy.

Lignite coal nephrotoxicity. We have been working with two geologists, Dr. R. Paul Philp at The University of Oklahoma in Norman, and Dr. Ann Ojeda at Auburn University to examine the nephrotoxic components of a low-rank coal called lignite, found in the gulf region of the US and the Balkan areas of europe. These components can leach into drinking water, particularly in private wells, and we have shown that lignite extracts are toxic to kidney cells in culture. Ongoing studies are examining the nephrotoxicity of these extracts in the drinking water in animals and determining which specific components of the extracts are nephrotoxic.






Education & Experience

Postdoctoral Fellow in Pharmacology

Fred Hutchinson Cancer Center, Seattle, WA

1999

Ph.D. in Pharmacology and Toxicology

Darmouth Medical School, Hanover, NH

1997

B.S. in Pharmacy (cum laude with honors and distinction)

The Ohio State University, Ohio

1989


Honors & Awards

Professional Awards

Best Publication Award

Society of Toxicology

Joanne I. Moore Professorship in Pharmacology

OU College of Medicine




Publications & Presentations

1 2 3 4 > >>
  1. Ojeda A S, Ford S D, Gallucci R, Ihnat M, Philp R P. Geochemical characterization and renal cell toxicity of water-soluble extracts from U.S. Gulf Coast lignite. Environ Geochem Health/Springer. 2018
  2. Devambatla RKV , Choudhary S, Ihnat M, Hamel E, Mooberry S L, Gangjee A. Design, synthesis and preclinical evaluation of 5-methyl-N4-aryl-furo[2,3-d]pyrimidines as single agents with combination chemotherapy potential. Bioorganic & medicinal chemistry letters. 2018; 28 : 3085-3093
  3. Xia D, Lai D V, Wu W, Webb Z D, Yang Q, Zhao L, Yu Z, Thorpe J E, Disch B C, Ihnat M, Jayaraman M, Dhanasekaran D N, Stratton K L, Cookson M S, Fung K M, Lin H K. Transition from androgenic to neurosteroidal action of 5α-androstane-3α, 17β-diol through the type A γ-aminobutyric acid receptor in prostate cancer progression. The Journal of steroid biochemistry and molecular biology. 2018; 178 : 89-98
  4. Zaware N, Kisliuk R, Bastian A, Ihnat M, Gangjee A. Synthesis and evaluation of 5-(arylthio)-9H-pyrimido [4,5-b] indole-2, 4-diamines as receptor tyrosine kinase and thymidylate synthase inhibitors and as antitumor agents. Bioorg Med Chem Lett. 2017; 27 : 1602-1607
  5. Luckett-Chastain L R, Smith M L, Mickle B M, Ihnat M, Gallucci R. Interleukin (IL)-6 modulates transforming growth factor -β receptor II (TGF-βRII) function in epidermal keratinocytes. Experimental Dermatology. 2017; 26 : 697-704
1 2 3 4 > >>